Simon Quick Advisors, LLC Incyte Corp Transaction History

Simon Quick Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 26, 2020	SELL	$85.07 - $109.69 $45,682 - $58,903	-537 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$74.18 - $108.93 $1,780 - $2,614	24 Added 4.68%	537 $56,000
Q1 2020 Apr 09, 2020	BUY	$63.18 - $85.97 $32,411 - $44,102	513 New	513 $38,000
Q3 2019 Oct 16, 2019	SELL	$72.82 - $86.52 $2,403 - $2,855	-33 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$73.52 - $88.7 $2,426 - $2,927	33 New	33 $0

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Simon Quick Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Simon Quick Advisors, LLC with notifications on news.